by Ming Mui | Jan 18, 2023 | Biotechnology, Healthcare, Investing News, Market News, Personal Finance, Technology, The Market Buzz
Moderna, Inc. (NASDAQ: MRNA) has announced positive data from its ConquerRSV Phase 3 trial of mRNA-1345, an investigational mRNA vaccine that targets respiratory syncytial virus in older adults. Following review by an independent Data and Safety Monitoring Board...
